REFERENCES
- Crimlisk HL (1997) The little imitator — porphyria: a neuropsychiatric disorder. J Neurol Neurosurg Psychiatry 62: 319–28.
- McColl KEL, Dover S, Fitzsimons E, Moore MR (1996) Porphyrin metabolism and the porphyrias. In: Weatherall DJ, Ledingham JGG, Warrell DA (eds) Oxford textbook of medicine, 3rd edition. Oxford: Oxford University Press: 1388—99.
- Lishman WA (1998) Endocrine diseases and metabolic disorders. In: Organic psychiatry: the psychological consequences of cerebral disorder, 3rd edition. London: Blackwell Science: 567—9.
- Anonymous (2001) Acute porphyrias. In: Mehta DK (ed.) British national formulary, Number 41. London: British Medical Association: 459–60.
- Gorchein A (1997) Drug treatment in acute porphyria. Br J Clin Pharmacol 44: 427–34.
- Strauss J, DiMartini A (1999) Use of olanzapine in hereditary coproporphyria. Psychosomatics 40: 444–5.
- Holroyd S, Seward RL (1999) Psychotropic drugs in acute intermittent porphyria. Clin Pharmacol Ther 66: 323–5.
- Stephenson CME, Pilowsky LS (1999) Psychopharmacology of olanzapine: A review. Br J Psychiatry 174(suppl. 38): 52—8.
- Anonymous (2001) Acute porphyrias. In: Mehta DK (eds) British national formulary, Number 41. London: British Medical Association: 174, 636.